explore -WSS

explore

author：entertainment 2025-10-01 18:35:19 - browse：85611

US Capitol - SOTU — Lawmakers in Congress have decided to punt efforts to reform how PBMs operate. BRENDAN SMIALOWSKI/AFP/Getty Images

WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government, 11 lobbyists and sources following the talks told STAT.

It’s a missed opportunity to pass one of the health care priorities that has attracted the most bipartisan interest and activity this Congress, though lawmakers could revive the negotiations on the issues in the future.

Reforming how pharmacy benefit managers operate has been a top lobbying priority for the pharmaceutical industry since Democrats passed a major package aimed at lowering the costs of medicines in 2022. Pharma and PBMs have taken up a very public battle on the airwaves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Abbott's new stent may help patients with peripheral artery disease

WSS

Biohaven protein

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

As H5N1 spreads in cows, experts warn against drinking raw milk

Do more moles mean more problems? Not so, says new study

Lilly’s weekly insulin works as well as daily products, new studies show

Dark money group runs ads on China biotech bill

hotspot

explore

leisure time

Alkermes shareholders re

CVS is willing to dump 10% of its Medicare Advantage members

Hepatitis C has a cure — but many Americans still lack access to it

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The United States must get value

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Stigma and the return of syphilis

Hollywood unions extend contract negotiations for actors

Lab trade group sues FDA to halt regulation of lab

leisure time

Fertility clinic egg and embryo storage is a disaster

WuXi Biologics beefs up its lobbying operation

Dark money group runs ads on China biotech bill

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

What a koala virus tells us about the human genome

ALS treatment from Biogen, Ionis fails in study

hotspot

focus

explore

knowledge